Skip to content

ASND

Ascendis Pharma A/S

NASDAQ · DKHealthcareBiotechnology
$251.76-3.54%

Price as of Jul 20, 2026

ASND capital

Ascendis Pharma A/S capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
1.84x
Net debt / equity
0.66x
Debt / assets
0.45x
Debt / EBITDA
72.56x
Net debt / EBITDA
26.21x

Liquidity & coverage

Current ratio
1.00x
Quick ratio
0.72x
Cash ratio
0.51x
Interest coverage
-0.04x
EBITDA / interest
0.07x
Working capital
-$5.1M

Cash & dividend

FCF / debt
0.05x
Cash flow / debt
0.06x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.